The Melanoma Letter Summer 2011, Vol. 29, No. 1

In this issue, Allan C. Halpern, MD, editor-in-chief of The Melanoma Letter, offers a concise yet panoramic overview of the current state of the art of melanoma research. Dr. Halpern explores the major strides made recently in virtually every area of melanoma investigation, from epidemiology, prevention, and detection to diagnosis, staging, and (most spectacularly) treatment. After decades of frustration for researchers, Dr. Halpern asserts, patients are at last starting to reap the benefits, and hopes for many more significant breakthroughs in the near future are soaring.